Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value

doi:10.5493/wjem.v15.i2.102761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (160)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-10) series.

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-10)

Sum=97

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=50

Publishing Process of This Article

Item

Count

Browse

Download

Sum=7

Jun 20, 2025 (publication date) through Apr 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Exp Med. Jun 20, 2025; 15(2): 102761
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.102761

Table 7 Results of the correlation analysis

Breast cancer characteristics	Gamma correlation	P value
Т stage	-0.240	0.022
Tumor grade	-0.160	0.133
Lymphovascular invasion	0.967	< 0.00001
Perineural invasion	0.380	0.003
ER status	0.606	0.00008
PR status	0.158	0.068
HER2 status	-0.359	0.029
Ki67 index	-0.114	0.147
Subtype	0.104	0.28
PDCD1 LG1+ LF score	-0.414	0.0004
Lymphocytes with nuclear expression of PDCD1 LG1	0.295	0.12
PDCD1 LG1+ polymorphic cellular infiltrations	0.151	0.105
PDCD1 LG1+ fibroblastic stroma	-0.029	0.796
PDCD1 LG1 expression in endothelial cells of tumor microvessels	0.289	0.011
SP142+ ICs	-0.283	0.033

ER: Estrogen receptor; HER2: Human epidermal growth factor receptor 2; ICs: Immune cells; LFs: Lymphocytes; PDCD1 LG1: Programmed cell death protein 1 ligand 1; PR: Progesterone receptor; TNBC: Triple-negative breast cancer.

Citation: Zubareva EY, Senchukova MA, Saidler NV. Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value. World J Exp Med 2025; 15(2): 102761
URL: https://www.wjgnet.com/2220-315x/full/v15/i2/102761.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i2.102761